Esketamine (Spravato®)
FDA-approved treatment for adults with treatment-resistant depression. Administered as a nasal spray under medical supervision, Spravato works differently from traditional antidepressants by targeting the brain’s glutamate system, helping to rapidly improve mood and reduce depressive symptoms.
For individuals who have not responded adequately to standard therapies, Spravato offers a new pathway toward relief often with faster results. Treatment is provided in a safe, monitored clinical setting as part of a comprehensive mental health care plan.
Please visit our Services section to learn more about how this treatment is offered and what to expect.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.